Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Taro Pharm Inds (TARO)

Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,615,114
  • Shares Outstanding, K 37,587
  • Annual Sales, $ 629,180 K
  • Annual Income, $ 53,870 K
  • 60-Month Beta 0.56
  • Price/Sales 2.57
  • Price/Cash Flow 18.03
  • Price/Book 0.90
Trade TARO with:
  • Price/Earnings ttm 24.28
  • Earnings Per Share ttm 1.77
  • Most Recent Earnings $0.43 on 05/20/24
  • Next Earnings Date 07/24/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 0.31
  • Number of Estimates 1
  • High Estimate 0.31
  • Low Estimate 0.31
  • Prior Year 0.18
  • Growth Rate Est. (year over year) +72.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
42.40 +1.34%
on 05/22/24
43.03 -0.14%
on 06/20/24
+0.45 (+1.06%)
since 05/21/24
3-Month
41.85 +2.68%
on 04/10/24
43.03 -0.14%
on 06/20/24
+0.78 (+1.85%)
since 03/21/24
52-Week
32.67 +31.53%
on 10/27/23
45.76 -6.10%
on 01/26/24
+2.47 (+6.10%)
since 06/21/23

Most Recent Stories

More News
Taro: Fiscal Q4 Earnings Snapshot

Taro: Fiscal Q4 Earnings Snapshot

TARO : 42.97 (unch)
Taro: Fiscal Q3 Earnings Snapshot

Taro: Fiscal Q3 Earnings Snapshot

TARO : 42.97 (unch)
Taro: Fiscal Q2 Earnings Snapshot

Taro: Fiscal Q2 Earnings Snapshot

TARO : 42.97 (unch)
Taro: Fiscal Q1 Earnings Snapshot

Taro: Fiscal Q1 Earnings Snapshot

TARO : 42.97 (unch)
Krensavage Asset Management Opposes Sun's Lowball Bid for Taro

/PRNewswire/ -- As the largest minority shareholder1 of Taro Pharmaceutical Industries Ltd. (NYSE: TARO), Krensavage Asset Management LLC opposes Sun...

TARO : 42.97 (unch)
Why Shares of Taro Pharmaceutical Are Rising Tuesday

The company is mulling a buyout offer from Sun Pharmaceutical.

TARO : 42.97 (unch)
Taro: Fiscal Q4 Earnings Snapshot

Taro: Fiscal Q4 Earnings Snapshot

TARO : 42.97 (unch)
Taro Provides Results for December 31, 2022

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and nine months ended December 31, 2022.

TARO : 42.97 (unch)
Taro to Release Third Quarter Results on January 24, 2023

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the third quarter ended December 31, 2022, after the close of market on Tuesday, January...

TARO : 42.97 (unch)
Taro: Fiscal Q2 Earnings Snapshot

Taro: Fiscal Q2 Earnings Snapshot

TARO : 42.97 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Taro Pharmaceutical Industries is engaged in the production, research and development, and marketing of prescription and over-the-counter pharmaceutical products, with a focus on generic products. In addition to the production of finished dosage form drugs, they also synthesize the pharmaceutical chemicals...

See More

Key Turning Points

3rd Resistance Point 43.09
2nd Resistance Point 43.04
1st Resistance Point 43.00
Last Price 42.97
1st Support Level 42.91
2nd Support Level 42.86
3rd Support Level 42.82

See More

52-Week High 45.76
Last Price 42.97
Fibonacci 61.8% 40.76
Fibonacci 50% 39.21
Fibonacci 38.2% 37.67
52-Week Low 32.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar